| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |